Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Bone Cells and Tissue

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR.

Breast cancer research : BCR·2024

Same author

Parathyroid hormone-related protein in breast cancer bone metastasis.

Vitamins and hormones·2022

Same author

G-CSF Receptor Deletion Amplifies Cortical Bone Dysfunction in Mice With STAT3 Hyperactivation in Osteocytes.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2022

Same author

PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway.

Frontiers in endocrinology·2022

Same author

Aspects of intercellular communication in bone and implications in therapy.

Bone·2021

Same author

Dmp1Cre-directed knockdown of parathyroid hormone-related protein (PTHrP) in murine decidua is associated with a life-long increase in bone mass, width, and strength in male progeny.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2021

Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026

Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026

Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026

Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026

Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026

Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Bone metastasis: can osteoclasts be excluded?

T John Martin¹, Gregory R Mundy

¹St Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australiajmartin@svi.edu.au.

|February 23, 2007

Summary

This summary is machine-generated.

Osteoprotegerin (OPG) inhibits bone metastasis by affecting cell migration via RANK, independent of osteoclast activity. This study questions the data supporting this novel mechanism in bone metastasis research.

More Related Videos

Osteoclast Derivation from Mouse Bone Marrow

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Related Experiment Videos

Last Updated: Jun 23, 2026

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Osteoclast Derivation from Mouse Bone Marrow

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Area of Science:

Oncology
Bone Biology
Signaling Pathways

Background:

The RANK/RANKL pathway is crucial for osteoclast function and is a target for inhibiting bone metastasis.
Inhibitors like OPG are known to suppress bone metastases, primarily attributed to their anti-osteoclast effects.

Discussion:

Jones et al. reported that OPG inhibits B16F10 melanoma bone metastasis independently of osteoclast resorption.
Their findings suggest OPG acts via RANK to influence cancer cell migration, a mechanism distinct from osteoclast modulation.

Key Insights:

This study challenges the established role of osteoclasts in mediating the effects of RANKL inhibitors on bone metastasis.
The proposed RANK-mediated effect on cancer cell migration offers a new perspective on metastasis.
The authors critically evaluate the evidence presented by Jones et al., questioning the robustness of their conclusions.

Outlook:

Further research is needed to validate the proposed RANK-dependent cell migration mechanism in bone metastasis.
Clarifying the precise role of RANK signaling in cancer cell behavior within the bone microenvironment is essential.
Re-evaluation of existing data and new experimental designs may be required to fully understand OPG's multifaceted actions.